Literature DB >> 9401010

Familial lipoprotein lipase (LPL) deficiency: a catalogue of LPL gene mutations identified in 20 patients from the UK, Sweden, and Italy.

F Mailly1, J Palmen, D P Muller, T Gibbs, J Lloyd, J Brunzell, P Durrington, K Mitropoulos, J Betteridge, G Watts, H Lithell, F Angelico, S E Humphries, P J Talmud.   

Abstract

The aim of this study was to identify mutations in the lipoprotein lipase (LPL) gene in 20 unrelated patients with familial lipoprotein deficiency (FLLD) and to investigate the genotype/phenotype relationship. The previously reported G188E mutation (Monsalve et al., J Clin Invest 86:728-734, 1990) was screened for and found to be present in seven individuals (12/40 alleles). In addition, three patients were heterozygous for the 2.0 kb insertion (Langlois et al., Proc Nalt Acad Sci US 86:948-952, 1989). Two approaches were taken for new mutation detection; single-strand conformation polymorphism and sequencing to identify micro-mutations in the proximal promoter and exons 1-9 of the LPL gene and Southern blotting to identify gross mutations. Ten different point mutations were found (W86G, A158T, H183Q, G188E, S193R, P207L, L252X, N291S, M301T, L303P). Additionally, a two nucleotide deletion in exon 6 (delta1006-1007), a six nucleotide deletion in exon 8 (delta1441-1447), and a silent substitution in the wobble position of codon E118 were identified. In vitro mutagenesis and expression in COS-B cells suggested that the A158T and S193R substitutions virtually abolished enzyme activity. In analysing the genotype/phenotype relationship, there was no strong association between age at diagnosis, severity of symptoms, lipid levels, and the nature/position of the mutation. Triglyceride levels, however, were higher in compound heterozygotes compared to true homozygotes, possibly reflecting increased instability of heterodimers. Overall, 29 of 40 (72.5%) mutant alleles were identified. Failure to identify the mutation in 11 alleles might reflect the inadequacy of the method or the possibility that mutations lie within regions of the gene not screened in the study because of lack of availability of sequence.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9401010     DOI: 10.1002/(SICI)1098-1004(1997)10:6<465::AID-HUMU8>3.0.CO;2-C

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  11 in total

1.  Genome scan for human obesity and linkage to markers in 20q13.

Authors:  J H Lee; D R Reed; W D Li; W Xu; E J Joo; R L Kilker; E Nanthakumar; M North; H Sakul; C Bell; R A Price
Journal:  Am J Hum Genet       Date:  1999-01       Impact factor: 11.025

Review 2.  The metabolic serine hydrolases and their functions in mammalian physiology and disease.

Authors:  Jonathan Z Long; Benjamin F Cravatt
Journal:  Chem Rev       Date:  2011-06-23       Impact factor: 60.622

Review 3.  Chylomicronemia from GPIHBP1 autoantibodies.

Authors:  Kazuya Miyashita; Jens Lutz; Lisa C Hudgins; Dana Toib; Ambika P Ashraf; Wenxin Song; Masami Murakami; Katsuyuki Nakajima; Michael Ploug; Loren G Fong; Stephen G Young; Anne P Beigneux
Journal:  J Lipid Res       Date:  2020-09-18       Impact factor: 5.922

Review 4.  Genetic determinants of plasma triglycerides: impact of rare and common mutations.

Authors:  P J Talmud
Journal:  Curr Atheroscler Rep       Date:  2001-05       Impact factor: 5.113

Review 5.  GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.

Authors:  Stephen G Young; Loren G Fong; Anne P Beigneux; Christopher M Allan; Cuiwen He; Haibo Jiang; Katsuyuki Nakajima; Muthuraman Meiyappan; Gabriel Birrane; Michael Ploug
Journal:  Cell Metab       Date:  2019-07-02       Impact factor: 27.287

Review 6.  Biochemistry and pathophysiology of intravascular and intracellular lipolysis.

Authors:  Stephen G Young; Rudolf Zechner
Journal:  Genes Dev       Date:  2013-03-01       Impact factor: 11.361

7.  Severe hypertriglyceridaemia in a Greek infant: a clinical, biochemical and genetic study.

Authors:  Emmanuel Kavazarakis; Stella Stabouli; Dimitrios Gourgiotis; Katerina Roumeliotou; Joanne Traeger-Synodinos; Apostolos Bossios; Andrew Fretzayas; Emmanuel Kanavakis
Journal:  Eur J Pediatr       Date:  2004-06-05       Impact factor: 3.183

8.  Diagnostic value of post-heparin lipase testing in detecting common genetic variants in the LPL and LIPC genes.

Authors:  Mandy van Hoek; Geesje M Dallinga-Thie; Ewout W Steyerberg; Eric J G Sijbrands
Journal:  Eur J Hum Genet       Date:  2009-04-15       Impact factor: 4.246

Review 9.  Common mutations of the lipoprotein lipase gene and their clinical significance.

Authors:  S Gehrisch
Journal:  Curr Atheroscler Rep       Date:  1999-07       Impact factor: 5.967

10.  Severe Hypertriglyceridemia due to a novel p.Q240H mutation in the Lipoprotein Lipase gene.

Authors:  Angela Ganan Soto; Adam McIntyre; Sungeeta Agrawal; Shara R Bialo; Robert A Hegele; Charlotte M Boney
Journal:  Lipids Health Dis       Date:  2015-09-04       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.